Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 162

1.

Identification of a global gene expression signature of B-chronic lymphocytic leukemia.

Jelinek DF, Tschumper RC, Stolovitzky GA, Iturria SJ, Tu Y, Lepre J, Shah N, Kay NE.

Mol Cancer Res. 2003 Mar;1(5):346-61.

PMID:
12651908
[PubMed - indexed for MEDLINE]
Free Article
2.

Deregulated expression of promyelocytic leukemia zinc finger protein in B-cell chronic lymphocytic leukemias does not affect cyclin A expression.

Parrado A, Noguera ME, Delmer A, McKenna S, Davies J, Le Gall I, Bentley P, Whittaker JA, Sigaux F, Chomienne C, Padua RA.

Hematol J. 2000;1(1):15-27.

PMID:
11920165
[PubMed - indexed for MEDLINE]
3.

Early gene activation in chronic leukemic B lymphocytes induced toward a plasma cell phenotype.

Segel GB, Woodlock TJ, Xu J, Li L, Felgar RE, Ryan DH, Lichtman MA, Wang N.

Blood Cells Mol Dis. 2003 May-Jun;30(3):277-87.

PMID:
12737946
[PubMed - indexed for MEDLINE]
4.

Transforming growth factor-beta (TGF-beta)-resistant B cells from chronic lymphocytic leukemia patients contain recurrent mutations in the signal sequence of the type I TGF-beta receptor.

Schiemann WP, Rotzer D, Pfeifer WM, Levi E, Rai KR, Knaus P, Kadin ME.

Cancer Detect Prev. 2004;28(1):57-64.

PMID:
15041079
[PubMed - indexed for MEDLINE]
5.

What do somatic hypermutation and class switch recombination teach us about chronic lymphocytic leukaemia pathogenesis?

Oppezzo P, Dighiero G.

Curr Top Microbiol Immunol. 2005;294:71-89. Review.

PMID:
16323428
[PubMed - indexed for MEDLINE]
6.

Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features.

Bomben R, Dal-Bo M, Benedetti D, Capello D, Forconi F, Marconi D, Bertoni F, Maffei R, Laurenti L, Rossi D, Del Principe MI, Luciano F, Sozzi E, Cattarossi I, Zucchetto A, Rossi FM, Bulian P, Zucca E, Nicoloso MS, Degan M, Marasca R, Efremov DG, Del Poeta G, Gaidano G, Gattei V.

Clin Cancer Res. 2010 Jan 15;16(2):620-8. doi: 10.1158/1078-0432.CCR-09-1638. Epub 2010 Jan 12.

PMID:
20068100
[PubMed - indexed for MEDLINE]
Free Article
7.

Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.

Mittal AK, Hegde GV, Aoun P, Bociek RG, Dave BJ, Joshi AD, Sanger WG, Weisenburger DD, Joshi SS.

Int J Mol Med. 2007 Oct;20(4):461-9.

PMID:
17786276
[PubMed - indexed for MEDLINE]
8.

Monoclonal B lymphocytes with the characteristics of "indolent" chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts.

Rawstron AC, Green MJ, Kuzmicki A, Kennedy B, Fenton JA, Evans PA, O'Connor SJ, Richards SJ, Morgan GJ, Jack AS, Hillmen P.

Blood. 2002 Jul 15;100(2):635-9.

PMID:
12091358
[PubMed - indexed for MEDLINE]
Free Article
9.

ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia.

Joshi AD, Hegde GV, Dickinson JD, Mittal AK, Lynch JC, Eudy JD, Armitage JO, Bierman PJ, Bociek RG, Devetten MP, Vose JM, Joshi SS.

Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5295-304.

PMID:
17875758
[PubMed - indexed for MEDLINE]
Free Article
10.

Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma.

Mikaelsson E, Danesh-Manesh AH, Lüppert A, Jeddi-Tehrani M, Rezvany MR, Sharifian RA, Safaie R, Roohi A, Osterborg A, Shokri F, Mellstedt H, Rabbani H.

Blood. 2005 Jun 15;105(12):4828-35. Epub 2005 Mar 1.

PMID:
15741214
[PubMed - indexed for MEDLINE]
Free Article
11.

Expression of RHAMM/CD168 and other tumor-associated antigens in patients with B-cell chronic lymphocytic leukemia.

Giannopoulos K, Li L, Bojarska-Junak A, Rolinski J, Dmoszynska A, Hus I, Greiner J, Renner C, Döhner H, Schmitt M.

Int J Oncol. 2006 Jul;29(1):95-103.

PMID:
16773189
[PubMed - indexed for MEDLINE]
12.

Overexpression of the paternally expressed gene 10 (PEG10) from the imprinted locus on chromosome 7q21 in high-risk B-cell chronic lymphocytic leukemia.

Kainz B, Shehata M, Bilban M, Kienle D, Heintel D, Krömer-Holzinger E, Le T, Kröber A, Heller G, Schwarzinger I, Demirtas D, Chott A, Döhner H, Zöchbauer-Müller S, Fonatsch C, Zielinski C, Stilgenbauer S, Gaiger A, Wagner O, Jäger U.

Int J Cancer. 2007 Nov 1;121(9):1984-93.

PMID:
17621626
[PubMed - indexed for MEDLINE]
13.

Lipoprotein lipase expression is a novel prognostic factor in B-cell chronic lymphocytic leukemia.

Nückel H, Hüttmann A, Klein-Hitpass L, Schroers R, Führer A, Sellmann L, Dührsen U, Dürig J.

Leuk Lymphoma. 2006 Jun;47(6):1053-61.

PMID:
16840197
[PubMed - indexed for MEDLINE]
14.

Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.

Molica S, Vitelli G, Mirabelli R, Digiesu G, Giannarelli D, Cuneo A, Ribatti D, Vacca A.

Eur J Haematol. 2006 Jan;76(1):51-7.

PMID:
16343271
[PubMed - indexed for MEDLINE]
15.

The resistance of B-CLL cells to DNA damage-induced apoptosis defined by DNA microarrays.

Vallat L, Magdelénat H, Merle-Béral H, Masdehors P, Potocki de Montalk G, Davi F, Kruhoffer M, Sabatier L, Orntoft TF, Delic J.

Blood. 2003 Jun 1;101(11):4598-606. Epub 2003 Feb 13.

PMID:
12586635
[PubMed - indexed for MEDLINE]
Free Article
16.

Lymphocytes from patients with early stage of B-cell chronic lymphocytic leukaemia and long survival synthesize decorin.

Campo S, Campo GM, Avenoso A, D'Ascola A, Musolino C, Calabrò L, Bellomo G, Quartarone E, Calatroni A.

Biochimie. 2006 Dec;88(12):1933-9. Epub 2006 Aug 7.

PMID:
16938379
[PubMed - indexed for MEDLINE]
17.

Translocation t(X;11)(q13;q23) in B-cell chronic lymphocytic leukemia disrupts two novel genes.

Kalla C, Nentwich H, Schlotter M, Mertens D, Wildenberger K, Döhner H, Stilgenbauer S, Lichter P.

Genes Chromosomes Cancer. 2005 Feb;42(2):128-43.

PMID:
15543602
[PubMed - indexed for MEDLINE]
18.

Resistance to CD95-mediated apoptosis of CD40-activated chronic lymphocytic leukemia B cells is not related to lack of DISC molecules expression.

de Totero D, Montera M, Rosso O, Clavio M, Balleari E, Foa R, Gobbi M.

Hematol J. 2004;5(2):152-60.

PMID:
15048066
[PubMed - indexed for MEDLINE]
19.

Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response.

Rosenwald A, Chuang EY, Davis RE, Wiestner A, Alizadeh AA, Arthur DC, Mitchell JB, Marti GE, Fowler DH, Wilson WH, Staudt LM.

Blood. 2004 Sep 1;104(5):1428-34. Epub 2004 May 11.

PMID:
15138159
[PubMed - indexed for MEDLINE]
Free Article
20.

Overexpression of the p73 gene is a novel finding in high-risk B-cell chronic lymphocytic leukemia.

Novak U, Grob TJ, Baskaynak G, Peters UR, Aebi S, Zwahlen D, Tschan MP, Kreuzer KA, Leibundgut EO, Cajot JF, Tobler A, Fey MF.

Ann Oncol. 2001 Jul;12(7):981-6.

PMID:
11521806
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk